CREFX | PHRAX | CREFX / PHRAX | |
Total Expense Ratio | 0.75 | 1.24 | 60% |
Annual Report Gross Expense Ratio | 0.75 | 1.37 | 55% |
Fund Existence | 8 years | 30 years | - |
Gain YTD | 3.631 | 0.541 | 672% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.03B | 361M | 2,224% |
Annual Yield % from dividends | 2.20 | 1.86 | 118% |
Returns for 1 year | 10.73 | 6.16 | 174% |
Returns for 3 years | 16.97 | -5.01 | -339% |
Returns for 5 years | 33.66 | 7.75 | 434% |
Returns for 10 years | N/A | -42.82 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OBIIX | 10.79 | -0.11 | -1.01% |
Oberweis International Opps Instl | |||
SPMIX | 24.57 | -0.38 | -1.52% |
Shelton S&P Midcap Index Investor | |||
WRGCX | 6.40 | -0.10 | -1.54% |
Macquarie Small Cap Growth C | |||
VEXMX | 140.69 | -2.43 | -1.70% |
Vanguard Extended Market Index Investor | |||
VSENX | 51.68 | -0.99 | -1.88% |
JPMorgan Small Cap Equity R6 |